128 related articles for article (PubMed ID: 21634378)
1. 13C-labeled heparan sulfate analogue as a tool to study protein/heparan sulfate interactions by NMR spectroscopy: application to the CXCL12α chemokine.
Laguri C; Sapay N; Simorre JP; Brutscher B; Imberty A; Gans P; Lortat-Jacob H
J Am Chem Soc; 2011 Jun; 133(25):9642-5. PubMed ID: 21634378
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the structural attributes of protein-heparan sulfate interactions using chemo-enzymatic approaches and NMR spectroscopy.
Préchoux A; Simorre JP; Lortat-Jacob H; Laguri C
Glycobiology; 2021 Aug; 31(7):851-858. PubMed ID: 33554262
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together.
Sapay N; Cabannes E; Petitou M; Imberty A
Glycobiology; 2011 Sep; 21(9):1181-93. PubMed ID: 21572110
[TBL] [Abstract][Full Text] [Related]
4. Structural diversity of heparan sulfate binding domains in chemokines.
Lortat-Jacob H; Grosdidier A; Imberty A
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1229-34. PubMed ID: 11830659
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis and functional implications of chemokine interactions with heparan sulphate.
Lortat-Jacob H
Curr Opin Struct Biol; 2009 Oct; 19(5):543-8. PubMed ID: 19800217
[TBL] [Abstract][Full Text] [Related]
6. Preparation of isotope-enriched heparan sulfate precursors for structural biology studies.
Victor XV; Tran VM; Kuberan B; Nguyen TK
Methods Mol Biol; 2015; 1229():43-8. PubMed ID: 25325943
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate-protein interactions--a concept for drug design?
Lindahl U
Thromb Haemost; 2007 Jul; 98(1):109-15. PubMed ID: 17598000
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and growth factors cross-link heparan sulfate.
Migliorini E; Thakar D; Kühnle J; Sadir R; Dyer DP; Li Y; Sun C; Volkman BF; Handel TM; Coche-Guerente L; Fernig DG; Lortat-Jacob H; Richter RP
Open Biol; 2015 Aug; 5(8):. PubMed ID: 26269427
[TBL] [Abstract][Full Text] [Related]
9. Structural studies of heparan sulfate hexasaccharides: new insights into iduronate conformational behavior.
Murphy KJ; McLay N; Pye DA
J Am Chem Soc; 2008 Sep; 130(37):12435-44. PubMed ID: 18722428
[TBL] [Abstract][Full Text] [Related]
10. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III.
Hernaiz M; Liu J; Rosenberg RD; Linhardt RJ
Biochem Biophys Res Commun; 2000 Sep; 276(1):292-7. PubMed ID: 11006120
[TBL] [Abstract][Full Text] [Related]
12. Conformational degeneracy restricts the effective information content of heparan sulfate.
Rudd TR; Yates EA
Mol Biosyst; 2010 May; 6(5):902-8. PubMed ID: 20567777
[TBL] [Abstract][Full Text] [Related]
13. Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate.
Xu D; Arnold K; Liu J
Curr Opin Struct Biol; 2018 Jun; 50():155-161. PubMed ID: 29684759
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.
Connell BJ; Sadir R; Baleux F; Laguri C; Kleman JP; Luo L; Arenzana-Seisdedos F; Lortat-Jacob H
Sci Signal; 2016 Nov; 9(452):ra107. PubMed ID: 27803285
[TBL] [Abstract][Full Text] [Related]
15. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.
Powell AK; Yates EA; Fernig DG; Turnbull JE
Glycobiology; 2004 Apr; 14(4):17R-30R. PubMed ID: 14718374
[TBL] [Abstract][Full Text] [Related]
16. Structural determinants of heparan sulfate interactions with Slit proteins.
Zhang F; Ronca F; Linhardt RJ; Margolis RU
Biochem Biophys Res Commun; 2004 Apr; 317(2):352-7. PubMed ID: 15063764
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of heparan sulphate and heparin oligosaccharides.
Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
[TBL] [Abstract][Full Text] [Related]
18. Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide.
Gonçalves E; Kitas E; Seelig J
Biochemistry; 2005 Feb; 44(7):2692-702. PubMed ID: 15709783
[TBL] [Abstract][Full Text] [Related]
19. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.
Monneau YR; Luo L; Sankaranarayanan NV; Nagarajan B; Vivès RR; Baleux F; Desai UR; Arenzana-Seidedos F; Lortat-Jacob H
Open Biol; 2017 Oct; 7(10):. PubMed ID: 29070611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
